RENAISSANCE TECHNOLOGIES LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1037389 NEW YORK, NY

Position in VRDN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$3,972,636

-$345,008 QoQ

Shares Held

203,100

-36.6% QoQ

Ownership

0.197%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. VRDN ranks #95 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,972,636	203,100	-36.6%	Shares	Sole	2026-05-14
2025-03-31	$4,317,644	320,300	-13.7%	Shares	Sole	2025-05-14
2024-12-31	$7,115,904	371,200	+522.8%	Shares	Sole	2025-02-13
2024-09-30	$1,355,900	59,600	-75.9%	Shares	Sole	2024-11-13
2024-06-30	$3,221,276	247,600	-5.4%	Shares	Sole	2024-08-09
2024-03-31	$4,582,367	261,700	+1853.0%	Shares	Sole	2024-05-13
2023-12-31	$291,852	13,400	-79.4%	Shares	Sole	2024-02-13
2023-09-30	$1,000,168	65,200	-14.2%	Shares	Sole	2023-11-14
2023-06-30	$1,808,040	76,000	+112.3%	Shares	Sole	2023-08-11
2023-03-31	$910,752	35,800	-64.8%	Shares	Sole	2023-05-12
2022-09-30	$2,083,816	101,600	+667.4%	Shares	Sole	2022-11-14
2021-03-31	$221,240	13,240	—	Shares	Sole	2021-05-13
No filing history on record for this holder in this stock.